Cargando…

Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment

INTRODUCTION: Methimazole (MMI) represents the conventional therapeutic agent for Graves’ disease (GD) hyperthyroidism, but MMI efficacy is limited since it marginally affects the underlying autoimmune process. In a previous study, we randomly assigned 42 newly diagnosed GD patients with insufficien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallo, Daniela, Bruno, Antonino, Gallazzi, Matteo, Cattaneo, Simona Antonia Maria, Veronesi, Giovanni, Genoni, Angelo, Tanda, Maria Laura, Bartalena, Luigi, Passi, Alberto, Piantanida, Eliana, Mortara, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141462/ https://www.ncbi.nlm.nih.gov/pubmed/37124743 http://dx.doi.org/10.3389/fendo.2023.1145811

Ejemplares similares

Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment
por: Gallo, Daniela, et al.
Publicado: (2022)

Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher
por: Gallo, Daniela, et al.
Publicado: (2020)

Regulatory T Cells in the Pathogenesis of Graves’ Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2023)

Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
por: Bartalena, Luigi, et al.
Publicado: (2020)

Change in newly diagnosed Graves’ disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression
por: Ippolito, S., et al.
Publicado: (2020)

Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020)

Current concepts regarding Graves’ orbitopathy
por: Bartalena, Luigi, et al.
Publicado: (2022)

A pilot study on the beneficial effects of additional selenium supplementation to methimazole for treating patients with Graves’ disease
por: XU, Bin, et al.
Publicado: (2019)

Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role?
por: Piantanida, Eliana, et al.
Publicado: (2017)

Methimazole-Induced Pleural Effusion in the Setting of Graves' Disease
por: Khine, Le Yu, et al.
Publicado: (2019)

How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases?
por: Gallo, Daniela, et al.
Publicado: (2023)

Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children
por: Rivkees, Scott A., et al.
Publicado: (2010)

Polyarthritis Caused by Methimazole in Two Japanese Patients with Graves’ Disease
por: Nihei, Hiroko, et al.
Publicado: (2013)

Impact of Methimazole Treatment on Magnesium Concentration and Lymphocytes Activation in Adolescents with Graves’ Disease
por: Klatka, Maria, et al.
Publicado: (2013)

Two Cases of Methimazole-Induced Insulin Autoimmune Syndrome in Graves' Disease
por: Roh, Eun, et al.
Publicado: (2013)

SUN-517 Methimazole-Induced Neutropenia in Premature Twins with Graves’ Disease
por: Ballestas, Estefania Rodriguez, et al.
Publicado: (2020)

A Rare Case of Anaphylaxis to Methimazole in a Patient With Graves’ Disease
por: Garg, Dave, et al.
Publicado: (2021)

Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease
por: Schneider Aguirre, Rebecca, et al.
Publicado: (2021)

FRI505 A Rare Case Of Methimazole Induced Grave Agranulocytosis
por: Barua, Nabonita, et al.
Publicado: (2023)

Antithyroid arthritis syndrome caused by methimazole in a patient with Graves’ disease
por: Kawasumi, Muneo, et al.
Publicado: (2023)

When primary hyperparathyroidism comes as good news
por: Gallo, Daniela, et al.
Publicado: (2020)

Insulin autoimmune syndrome induced by methimazole in a Korean girl with Graves' disease
por: Lee, Sun Hee, et al.
Publicado: (2013)

Clinical effect of methimazole combined with selenium in the treatment of toxic diffuse goiter in children
por: Zhang, Xiao-Hong, et al.
Publicado: (2022)

Initial Treatment of Pediatric Graves’ Disease with Methimazole: A Retrospective Follow-up Study
por: Matsushita, Rie, et al.
Publicado: (2010)

Delayed methimazole-induced agranulocytosis in a 6-year old patient with Graves’ disease
por: Puthenpura, Vidya, et al.
Publicado: (2016)

Evaluating the Role of Circulating Dendritic Cells in Methimazole-Treated Pediatric Graves’ Disease Patients
por: Starosz, Aleksandra, et al.
Publicado: (2021)

Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
por: Azizi, Fereidoun, et al.
Publicado: (2021)

Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves’ Disease
por: Wijaya, Natalia, et al.
Publicado: (2019)

Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
por: Lee, Hyun Gyung, et al.
Publicado: (2021)

THU669 Time To Achieve Euthyroidism In Graves Disease Using Methimazole In An Urban Population
por: Sultana Habbsa, Samima, et al.
Publicado: (2023)

A Case of Hypocalcemia with Severe Vitamin D Deficiency following Treatment for Graves' Disease with Methimazole
por: Miyashita, Kazuyuki, et al.
Publicado: (2013)

Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
por: Azizi, Fereidoun, et al.
Publicado: (2021)

Very rare case of Graves’ disease with resistance to methimazole: a case report and literature review
por: Mori, Yusaku, et al.
Publicado: (2021)

Preliminary Observation of the Changes in the Intestinal Flora of Patients With Graves’ Disease Before and After Methimazole Treatment
por: Yang, Mengxue, et al.
Publicado: (2022)

Long-term methimazole therapy in Graves’ hyperthyroidism and adverse reactions: a Danish multicenter study
por: Karmisholt, J, et al.
Publicado: (2022)

Role of teprotumumab in the treatment of active moderate-to-severe Graves’ orbitopathy
por: Bartalena, Luigi
Publicado: (2022)

Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study
por: Rebecchi, Valentina, et al.
Publicado: (2021)

SAT-625 Dose-Dependent, Methimazole-Induced Agranulocytosis in a Pregnant Hispanic Woman with Grave's Disease
por: Bello, Fatimah, et al.
Publicado: (2019)

Methimazole-induced insulin autoimmune syndrome in Graves' disease with hypokalemia: A case report and literature review
por: Han, Rongfeng, et al.
Publicado: (2020)

Profound Hypothyroidism 21 Days After Methimazole Initiation in a Patient With Graves’s Disease and Liver Cirrhosis
por: Hammami, Safa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5d36c2dsbh2028n8avmmjcb3o5